Pernix Therapeutics Holdings Inc (PTXTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 146,068 | 140,856 | 175,850 | 121,747 | 84,872 |
| Cost of Goods | 44,631 | 43,320 | 51,408 | 47,965 | 43,870 |
| Gross Profit | 101,437 | 97,536 | 124,442 | 73,782 | 41,002 |
| Operating Expenses | 158,527 | 238,184 | 226,104 | 104,961 | 95,728 |
| Operating Income | -56,459 | -140,328 | -101,254 | -30,214 | -53,856 |
| Interest Expense | 36,957 | 37,857 | 38,277 | 19,150 | 4,183 |
| Other Income | 16,648 | 9,034 | -1,722 | 353 | 11,647 |
| Pre-tax Income | -76,768 | -169,151 | -141,253 | -49,011 | -46,392 |
| Income Tax | 373 | 439 | 7,062 | -13,725 | -20,757 |
| Net Income Continuous | -77,141 | -169,590 | -148,315 | -35,286 | -25,635 |
| Net Income | $-77,141 | $-169,590 | $-148,315 | $-35,286 | $-25,635 |
| EPS Basic Total Ops | -7.21 | -21.67 | -27.81 | -9.30 | -7.00 |
| EPS Basic Continuous Ops | -7.21 | -21.67 | -27.81 | -9.32 | -7.03 |
| EPS Diluted Total Ops | -7.21 | -21.67 | -27.81 | -9.30 | -7.00 |
| EPS Diluted Continuous Ops | -7.21 | -21.67 | -27.81 | -9.32 | -7.03 |
| EPS Diluted Before Non-Recurring Items | -8.20 | -14.76 | -7.40 | 1.10 | -3.80 |
| EBITDA(a) | $25,451 | $-47,616 | $-1,543 | $5,118 | $-43,885 |